I want to understand each patient's metabolic health, medication history, and goals before we choose a medication and dose strategy
GLP-1R and amylin agonism in metabolic disease: complementary mechanisms and future opportunities
Semaglutide activates GLP-1 receptors to promote satiety and slower digestion, while tirzepatide targets both GLP-1 and GIP, which may lead to greater and sometimes faster weight loss
The polyphenols ability to cross the blood-brain barrier facilitates direct neural tissue intervention, promoting neurogenesis, enhancing synaptic plasticity, and potentially modulating neuroinflammatory responses
Ascorbate (vitamin C) and GSH cooperate through redox cycling
Monotherapy with GLP-1 receptor agonist, lixisenatide, significantly improves glycaemic control in type 2 diabetic patients [abstract 830]